Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics: will the regulators approve?

Nature biotechnology - 1 Mar 1998

Hodgson J, Marshall A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Cytochrome P-450 Enzyme System
Share to Drug Approval
Share to Drug Industry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Guidelines as Topic

Share to London

Share to Pharmacogenetics

Share to United States Food and Drug Administration

Source

Identifiers

PMID: 9528002
DOI: 10.1038/nbt0398-243

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics: will the regulators approve?PMID 9528002Read ↗

Why pharmacogenomics? Why now?Semantic proximity Read ↗

Ethical, social and legal issues in pharmacogenomicsSemantic proximity Read ↗

Pharmacogenomics: time to rethink its role in precision medicine.Semantic proximity Read ↗

Ask the experts: pharmacogenomics and genome-wide association studies.Semantic proximity Read ↗

Pharmacogenetics becomes pharmacogenomics: wake up and get ready.Semantic proximity Read ↗

Pharmacogenomics: playing the odds.Semantic proximity Read ↗

Clinical and moral challenges of pharmacogenomics.Semantic proximity Read ↗

Ethical considerations in clinical pharmacogenomics researchSemantic proximity Read ↗

Pharmacogenomics in drug development: societal and technical aspects.Semantic proximity Read ↗

Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs.Semantic proximity Read ↗

Real-world Clinical Effectiveness, Regulatory Transparency and Payer Coverage: Three Ingredients for Translating Pharmacogenomics into Clinical PracticeSemantic proximity Read ↗

Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.